Composition: Imatinib Mesylate (100 mg)
Imacy-100 is an anti-cancer medicine containing Imatinib Mesylate, a targeted therapy known as a tyrosine kinase inhibitor. It is widely used in the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GISTs). Imacy-100 works by blocking abnormal proteins that trigger uncontrolled cell growth, thereby slowing or stopping cancer progression. With proven efficacy, it helps improve survival rates and quality of life in patients requiring long-term cancer management.